Niva Bupa Health Insurance Q3 Results 2026 Highlights: Net Profit Falls by 761.93% & Revenue Up 27.98% YoY
Updated: 2 Feb 2026 • 7:32 pm
Posted by:
Click and Sign Up to Get Live Updates on Q3 Results
Niva Bupa Health Insurance Q3 Results FY26: During Q3 FY26, Niva Bupa Health Insurance's profit decreased by 761.93% YoY, while revenue increased by 27.98% YoY. The company posted robust numbers, with Q3 PAT at -₹87.64 crores and revenue at ₹1,453.57 crores. Niva Bupa Health Insurance showed its Q3 results on 29th January 2026.
Niva Bupa Health Insurance Q3 Results FY26: Extracts of FY25 & FY26
| Particulars | Standalone Figures | |
| 31st Dec 2025 | 31st Dec 2024 | |
| Revenue from Operations | ₹1,453.57 | ₹1,135.80 |
| Profit Before Tax (PBT) | -₹87.64 | ₹13.24 |
| Profit After Tax (PAT) | -₹87.64 | ₹13.24 |
Niva Bupa Health Insurance Q3 Results FY26 Highlights (Q3 FY26 vs FY25)
- Niva Bupa Health Insurance clocked Q3 FY26 standalone revenue of ₹1,453.57 crores vs ₹1,135.80 crores.
- On the profit front, Niva Bupa Health Insurance earned a standalone PAT of -₹87.64 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹13.24 crore.
- According to the standalone figures, Niva Bupa Health Insurance's quarterly PAT decreased by 761.93% YoY, while revenue increased by 27.98%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Niva Bupa Health Insurance Share Price Performance
On the opening bell on 2nd February 2026, Niva Bupa Health Insurance shares opened at ₹77.28 per share. However, the initial gains have since eroded, and Niva Bupa Health Insurance's shares are currently trading at ₹79.22 per share, which is higher than the opening price.
Considering the long-term performance, Niva Bupa Health Insurance shares have yielded returns of approximately -3.39% over the past 6 months and -2.40% over the past 1 year. Over the maximum timeframe, Niva Bupa Health Insurance shares delivered a 7.03% return to investors.
What Analysts Expect Post Q3 Results?
Following Niva Bupa Health Insurance's robust Q3 results for FY26, analysts expect its share price to rise. According to analysts, Niva Bupa Health Insurance's share price could reach ₹125.65 per share in the coming year and, in a downturn, hit ₹63.55 per share. However, one must ignore stock market volatility and invest in Niva Bupa Health Insurance shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Reliance Infrastructure Q3 Results 2026 Highlights: Net Profit Rises by 9.85% & Revenue Up 0.00% YoY
RR Kabel Q3 Results 2026 Highlights: Net Profit Rises by 72.44% & Revenue Up 42.29% YoY
Nitin Spinners Q3 Results 2026 Highlights: Net Profit Falls by 0.81% & Revenue Down 4.55% YoY
Moschip Technologies Q3 Results 2026 Highlights: Net Profit Falls by 60.80% & Revenue Up 18.12% YoY
Hyundai Motor India Gears Up for Q3 Reveal on 2nd February; Check Key Expectations Here
Recent Articles
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
30 October 2026
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
30 October 2026
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
30 October 2026
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
Asian Paints Share Price After Q2 Results: Profit Up 7%, but Price Hikes Are Yet to Brighten Margins
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times